Puma Biotechnology Inc (PBYI)
Featured in
Small-Cap Stocks
Puma Biotechnology Inc (PBYI) is a NASDAQ-listed healthcare company in the biotechnology industry. Puma Biotechnology Inc common stock is an equity security, so the listed instrument represents a share of ownership in the company rather than a separate fund or debt issue. The business is associated with the development and commercialization of therapies for cancer care, with a focus on oncology-related research and product activity. As a common stock listing on NASDAQ, the security reflects the market trading of the company’s ordinary shares and is tied to the performance and prospects of the underlying business.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-PBYI
|
$9.37
|
8.8% Upside
|
Fair
|
$5
|
-41.9% Downside
|
Overvalued
|
Great
|
—
|
—
|
—
|
0.0%
|
July 30, 2026
|
17.9x
|
3.4x
|
1.9x
|
422.5 M
|
350.1 M
|
3.6%
|
76.4%
|
-5.0
|
—
|
219.8%
|
